Skip to main content

Are you Dr. Lee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 15 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Seok Lee, MD is a family physician in Pawtucket, Rhode Island. She is currently licensed to practice medicine in Rhode Island and Massachusetts.

Education & Training

  • New York Medical College (Brooklyn-Queens)
    New York Medical College (Brooklyn-Queens)Residency, Family Medicine, 1988 - 1991
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1982 - 1984
  • Brown University
    Brown UniversityResidency, Pathology-Anatomic and Clinical, 1977 - 1982
  • Children's Hospital
    Children's HospitalResidency, Pediatric Pathology, 1963 - 1965
  • Childrens Hospital
    Childrens HospitalInternship, Transitional Year, 1962 - 1963
  • Korea University College of Medicine
    Korea University College of MedicineClass of 1961

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 1984 - 2022
  • MA State Medical License
    MA State Medical License 1991 - 2016

Press Mentions

  • Johns Hopkins Bloomberg School of Public Health Appoints Marsha Wills-Karp as New Bloomberg Centennial Professor
    Johns Hopkins Bloomberg School of Public Health Appoints Marsha Wills-Karp as New Bloomberg Centennial ProfessorAugust 5th, 2021
  • Incidence and Risk Factors of Hepatic Veno-Occlusive disease/sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation in Adults with Prophylactic Ursodiol and Intravenous Heparin or Prostaglandin E1
    Incidence and Risk Factors of Hepatic Veno-Occlusive disease/sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation in Adults with Prophylactic Ursodiol and Intravenous Heparin or Prostaglandin E1February 1st, 2021
  • Impact of Donor Type on Long-Term Graft-Versus-Host disease-free/relapse-free Survival for Adult Acute Lymphoblastic Leukemia in First Remission
    Impact of Donor Type on Long-Term Graft-Versus-Host disease-free/relapse-free Survival for Adult Acute Lymphoblastic Leukemia in First RemissionOctober 30th, 2020